ACL — Australian Clinical Labs Share News
0.000.00%
Last trade - 00:00- AU$529.23m
- AU$841.21m
- AU$735.75m
Australian Clinical Labs falls after Healius rejects buyout bid
Brief: Healius Ltd Board Recommends Shareholders Reject Australian Clinical Labs' Offer
Australia's Healius rejects $1 bln buyout offer by Australian Clinical Labs
Jefferies sees inflationary woes negatively affecting Australia's Healius
Brief: Australian Govt Takeovers Panel Says It Declines To Conduct Proceedings On Healius
Brief: Australia's ACCC Says Commenced Review Of Proposed Takeover Of Healius By Australian Clinical Labs
Factbox: Australia Inc roiled by raft of cyber attacks since late 2022
Australia's Healius takeover bid unlikely to get ACCC nod, says brokerage Jefferies
Brief: Healius Confirms Receipt Of Off-Market Takeover Bid From Australian Clinical Labs
Australia's Healius climbs on getting $1 bln bid from Australian Clinical Labs
Australian Clinical Labs offers to buy Healius for $1 billion (updated)
Brief: Australian Clinical Labs Intends To Make Off-Market Takeover Offer To Acquire Healius
Australian Clinical Labs to buy Healius for $1 billion
Factbox: Australia Inc roiled by raft of cyberattacks since late 2022
Australian Clinical Labs rises as non-COVID revenue rebounds
Brief: Australian Clinical Labs Sees Low, Double-Digit EBIT Margins Achievable In Future
Brief: Australian Clinical Labs Says HY Total Revenue From Ordinary Activities Down 33.03% To A$360.3M
Australian healthcare firms face lagging core business, cost pressures - Citi
Factbox: Australia Inc roiled by raft of cyberattacks this year